Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-004714
Filing Date
2022-02-15
Accepted
2022-02-15 19:38:01
Documents
1
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4071
  Complete submission text file 0001493152-22-004714.txt   5522
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6725 MESA RIDGE ROAD SUITE 100 SAN DIEGO CA 92121
Business Address
Culley Brian M (Reporting) CIK: 0001310683 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 22640937